LAMB2 and neoplasm: EHS tumor–derived BMEs contain heterogenous mixtures of extracellular matrix proteins, primarily laminins, collagen IV, entactin, and perlecan as well as tumor-derived proteins and growth factors, which contribute to batch-to-batch variability (18, 19).